Bioequivalence Study of Tafolecimab Injections in Chinese Healthy Male Volunteers

Clinical trial NCT05792917 · COMPLETED

Trial details

NCT number: NCT05792917
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Subjects

Start date: 2023-03-06
Primary completion: 2023-03-26
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.